Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, pursuant to the Answer of 7 July 2014, Official Report, column 43W, on ovarian hyperstimulation syndrome, what information the Human Fertilisation and Embryology Authority (HFEA) collects about the (a) identity of drugs used in treatment and (b) dosage used and the associated regimen for ovarian stimulation at each clinic; and what comparative assessment he has made of the collection of such data by the HFEA and by other countries that report data to the European Society of Human Reproduction and Embryology.

The Human Fertilisation and Embryology Authority has advised that it does not collect information on the identity of drugs used in treatment, the dosage used and the associated regimen for ovarian stimulation at each licenced centre. As a result, no comparison has been made with data collected by countries submitting information to the European Society of Human Reproduction and Embryology.